The C2orf81 Knockout HEK293T Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout cell population targeting the C2orf81 gene in the human HEK293T cell line. This reagent is designed to investigate the functional consequences of C2orf81 loss, a gene implicated in cellular proliferation and survival. The polyclonal pool comprises a mixed population of cells with CRISPR-mediated gene disruption, offering a stable loss-of-function model suitable for reproducible phenotypic analyses without the need for continuous selection or transient knockdown.
HEK293T cells are a widely utilized derivative of HEK293 human embryonic kidney cells, stably expressing the SV40 large T antigen. This genetic modification permits episomal replication of plasmids containing the SV40 origin of replication, significantly boosting protein expression and viral production. Initially generated by transformation with sheared adenovirus type 5 DNA, these adherent epithelial cells retain kidney lineage characteristics and exhibit robust growth. Their extensively characterized genome and high transfection efficiency make them a preferred host for cell biology research, including studies of cell cycle regulation and oncogenic transformation.
The molecular function of C2orf81 remains poorly defined, with no experimentally confirmed upstream regulators, downstream targets, or interacting partners. Current evidence suggests a possible role in cell proliferation and survival, potentially intersecting with cell cycle progression or apoptotic pathways. However, the specific signaling mechanisms and molecular interactions governing C2orf81 activity are entirely unknown. The CRISPR knockout approach in HEK293T cells provides a powerful system to dissect these functions through unbiased phenotypic screening, interactome mapping, and transcriptomic profiling, facilitating the discovery of novel regulatory networks.
In the HEK293T context, ablation of C2orf81 enables the systematic exploration of its contribution to cellular growth control and stress responses. The host cell’s compromised cell cycle checkpoints, due to adenoviral and SV40 oncoproteins, create a sensitized background for revealing proliferation-related phenotypes. Moreover, the polyclonal knockout format minimizes clonal variability, enhancing the reliability of observed effects in assays such as viability measurements and cell cycle analysis, and supporting statistically robust comparisons.
Typical research applications include functional characterization via western blotting and RT-qPCR, cell viability and proliferation assays, flow cytometry-based cell cycle analysis, and co-immunoprecipitation for protein interaction studies. Transcriptome-wide analysis using RNA-seq can further elucidate downstream gene expression changes. This knockout cell model is particularly valuable for exploratory studies in cancer biology, where C2orf81 may have uncharacterized oncogenic or tumor-suppressive roles. For additional product specifications and technical support, please contact Ascent Research.
